Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Ligand Pharmaceuticals 2020 Investor Day

Learn MORE »
Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb® Antibodies

Read More

Ligand’s Partner Sedor Pharmaceuticals Receives FDA Approval for SESQUIENT™ for the Treatment of Status Epilepticus in Adult and Pediatric Patients

Read More

Ligand Reports Third Quarter 2020 Financial Results

Read More

Recent Events

Upcoming Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range